Pathologic outcomes in patients with clinically low-risk prostate cancer deemed eligible for active surveillance

被引：0
|
作者：
Srivastava, A. [1 ]
Grover, S. [1 ]
Sooriakumaran, P. [1 ]
Rajan, S. [1 ]
El-Douaihy, Y. [1 ]
Tewari, A. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
110
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients
    Xu, Jinping
    Bock, Cathryn
    Janisse, James
    Schwartz, Kendra L.
    Triest, Jeffrey
    Cher, Michael L.
    Goodman, Michael
    UROLOGY, 2021, 155 : 83 - 89
  • [32] A SYSTEMATIC APPROACH TO DISCUSSING ACTIVE SURVEILLANCE TO PATIENTS WITH LOW-RISK PROSTATE CANCER
    Ehdaie, Behfar
    Asset, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    JOURNAL OF UROLOGY, 2016, 195 (04): : E409 - E409
  • [33] PREDICTING PROGRESSION IN PATIENTS FOLLOWED WITH ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Sternberg, Itay
    Yu, Changhong
    Paz, Gal Keren
    Kim, Philip
    Bernstein, Melanie
    Lakin, Paul
    Kattan, Michael
    Ehdaie, Behfar
    Laudone, Vincent
    Scardino, Peter
    Eastham, James
    Touijer, Karim
    JOURNAL OF UROLOGY, 2014, 191 (04): : E459 - E459
  • [34] How useful is immunohistochemistry in patients on active surveillance for low-risk prostate cancer?
    Eldefrawy, A.
    Ransford, G.
    Pan, D.
    Umar, S.
    Jorda, M.
    Soloway, M. S.
    BJU INTERNATIONAL, 2013, 111 : 38 - 39
  • [35] Active surveillance can reduce overtreatment in patients with low-risk prostate cancer
    Thomsen, Frederik Birkaebk
    Roder, Martin Andreas
    Hvarness, Helle
    Iversen, Peter
    Brasso, Klaus
    DANISH MEDICAL JOURNAL, 2013, 60 (02):
  • [36] Predicting progression in patients followed with active surveillance for low-risk prostate cancer
    Sternberg, Itay Aharon
    Yu, Changhong
    Paz, Gal Elimelech Keren
    Kim, Philip H.
    Bernstein, Melanie
    Lakin, Paul
    Kattan, Michael W.
    Ehdaie, Behdar
    Laudone, Vincent Paul
    Scardino, Peter T.
    Eastham, James Andrew
    Touijer, Karim A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [37] A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer
    Ehdaie, Behfar
    Assel, Melissa
    Benfante, Nicole
    Malhotra, Deepak
    Vickers, Andrew
    EUROPEAN UROLOGY, 2017, 71 (06) : 866 - 871
  • [38] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Badrinath R Konety
    Nature Clinical Practice Urology, 2008, 5 : 277 - 283
  • [39] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [40] Active Surveillance for Black Men With Low-Risk Prostate Cancer
    Shen, Xinglei
    Pettaway, Curtis A.
    Chen, Ronald C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1733 - 1734
12345